Historical record - last NADAC effective date: 4/9/2020
Product Information
MYTESI 125 MG DR TABLET is a brand product labeled by Napo Pharmaceuticals, Inc., priced at $35.7266 per EA under NDC 70564080260. Its NADAC has been published 65 times since Jan 22, 2020.
FDA first approved this application on Dec 31, 2012.
Strength
125 mg/1
Manufacturer
Napo Pharmaceuticals, Inc.NDC
70564080260
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
4/9/2020
Active Ingredients
CROFELEMERApproval Type
New Drug (NDA)
FDA Application
NDA202292FDA Approved
12/31/2012
On Market Since
8/1/2016
Pharmacological Classes
Price Statistics
The NADAC for MYTESI 125 MG DR TABLET has been published 65 times since Jan 22, 2020, and over the history we have for it it has risen 230.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $35.7266 per EA |
|---|---|
| All-time high | $35.7266 (Apr 14, 2021) |
| All-time low | $10.8262 (Jan 22, 2020) |
| Median price | $35.7266 |
| Average price | $30.7465 |
| Largest weekly change | +230.0% (Apr 22, 2020) |
| Weeks tracked | 65 |
| Tracking since | Jan 22, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+230.0%
Last surveyed Apr 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Crofelemer market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MYTESI 125 MG DR TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MYTESI 125 MG DR TABLET, manufactured by Napo Pharmaceuticals, Inc., is $35.7266 per EA (NDC 70564080260), effective Apr 14, 2021.
How has the price of MYTESI 125 MG DR TABLET changed over time?
Over the history we have for it, the NADAC for MYTESI 125 MG DR TABLET has risen 230.0%. It has been tracked across 65 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for MYTESI 125 MG DR TABLET?
Since Jan 22, 2020, the NADAC for MYTESI 125 MG DR TABLET has ranged from a low of $10.8262 (Jan 22, 2020) to a high of $35.7266 (Apr 14, 2021), with a median of $35.7266 per EA.
Are there cheaper alternatives to MYTESI 125 MG DR TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MYTESI 125 MG DR TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MYTESI 125 MG DR TABLET?
MYTESI 125 MG DR TABLET (NDC 70564080260) is labeled by Napo Pharmaceuticals, Inc., and CMS classifies it as a brand product.